Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Century Therapeutics
IPSC
$364M
| $1.13M | ﹤0.01% |
+38,668
| New | +$981K |
|
3527
Beasley Broadcasting Group
BBGI
$37.8M
| $1.13M | ﹤0.01% |
19,618
-1,007
| -5% | -$56.2K |
|
3528
OP Bancorp
OPBK
$232M
| $1.13M | ﹤0.01% |
112,498
-77,895
| -41% | -$815K |
|
3529
LiqTech
LIQT
$23M
| $1.13M | ﹤0.01% |
19,312
| – | – |
|
3530
SELLAS Life Sciences
SLS
$1.97B
| $1.12M | ﹤0.01% |
101,337
+6,430
| +7% | +$62.8K |
|
3531
Meridian
MRBK
$234M
| $1.12M | ﹤0.01% |
85,392
-69,650
| -45% | -$915K |
|
|
NBSE
3532
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1.12M | ﹤0.01% |
11,693
-4,083
| -26% | -$451K |
|
|
FSTX
3533
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $1.12M | ﹤0.01% |
130,279
+75,279
| +137% | +$642K |
|
3534
Woori Financial
WF
$16.7B
| $1.11M | ﹤0.01% |
36,813
-1,390
| -4% | -$41K |
|
|
SIOX
3535
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.11M | ﹤0.01% |
408,087
+360,218
| +753% | +$896K |
|
3536
Alamos Gold
AGI
$11.6B
| $1.11M | ﹤0.01% |
145,669
+19,197
| +15% | +$164K |
|
|
PACX
3537
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
| $1.11M | ﹤0.01% |
112,204
+98,537
| +721% | +$969K |
|
3538
AYTU BioPharma
AYTU
$23.9M
| $1.11M | ﹤0.01% |
11,072
-7,007
| -39% | -$822K |
|
|
ENZ
3539
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.11M | ﹤0.01% |
349,221
-310,804
| -47% | -$978K |
|
3540
Honda
HMC
$39.1B
| $1.1M | ﹤0.01% |
34,330
+4,551
| +15% | +$141K |
|
3541
Larimar Therapeutics
LRMR
$397M
| $1.1M | ﹤0.01% |
112,454
+11,020
| +11% | +$125K |
|
|
VISL
3542
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $1.1M | ﹤0.01% |
19,375
+2,323
| +14% | +$121K |
|
3543
Graham Corp
GHM
$1.12B
| $1.1M | ﹤0.01% |
80,090
-57,930
| -42% | -$822K |
|
3544
Quad
QUAD
$536M
| $1.1M | ﹤0.01% |
265,086
-222,619
| -46% | -$807K |
|
3545
Silvercrest Asset Management
SAMG
$79M
| $1.1M | ﹤0.01% |
73,191
-58,845
| -45% | -$891K |
|
|
SAL
3546
DELISTED
Salisbury Bancorp, Inc.
SAL
| $1.1M | ﹤0.01% |
43,316
-32,450
| -43% | -$746K |
|
3547
Intapp
INTA
$2.52B
| $1.1M | ﹤0.01% |
+41,500
| New | +$1.16M |
|
3548
Liquidia Corp
LQDA
$7.48B
| $1.1M | ﹤0.01% |
384,481
-145,374
| -27% | -$403K |
|
3549
Choiceone Financial
COFS
$509M
| $1.1M | ﹤0.01% |
45,296
-47,967
| -51% | -$1.19M |
|
3550
Peoples Bancorp of North Carolina
PEBK
$229M
| $1.09M | ﹤0.01% |
42,465
-28,966
| -41% | -$705K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.